Drugs / P-552
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01369589 | Nov 2010 → Apr 2011 | Sjogren syndrome, xerophthalmia | Parion Sciences | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2017-11-01 | Aytu BioPharma, Inc. | Results Aytu BioScience Presents Clinical Findings for its MiOXSYS® System at 73rd Annual Meeting of the American Society of Reproductive Medicine aytubio.com ↗
The measurements for ORP among infertile men were consistent between centers in the USA and Qatar and with previous studies conducted by our group. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2017-11-01 | Aytu BioPharma, Inc. | Aytu BioScience Presents Clinical Findings for its MiOXSYS® System at 73rd Annual Meeting of the American Society of Reproductive Medicine aytubio.com ↗ |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | P-552 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01369589 ↗ |